Qure: The AI That Reads Medical Scans Like a Doctor - Only Faster, Cheaper, and Everywhere

What if a single algorithm could catch tuberculosis in a slum, a stroke in an ER, and a tumour in a refugee camp—all before a doctor walks in?

The Problem: Billions of People, Not Enough Radiologists

In the majority of the globe, medical imaging exists—but brains trained to read it don't.

Chest X-ray is taken—but no one is there to see the tuberculosis.

Stroke patient comes in—but the CT scan is not examined.

Equipment exists at clinics, but no radiologist in hundreds of kilometres.

Lives hang by thin threads while the reports delay for hours, even days. In emergencies, every second matters.

Welcome Qure.ai

Founded in 2016 in Mumbai by Prashant Warier, Qure.ai is leading the charge in using deep learning to enable medical image interpretation to be instant, reliable, and universally scalable.

The company creates AI solutions that not only detect diseases—but help prioritize the most critical cases, automated reports, and operate even in low-resource settings.

Whether it is a public hospital in India, a mobile TB van in Kenya, or a refugee camp in Jordan, Qure.ai technology is on the frontlines.

Flagship AI Products

qXR – AI for Chest X-Rays

Identifies 35+ abnormalities: TB, pneumonia, lung cancer, fibrosis, COVID-19, etc.

Reports in seconds with localized heatmaps and severity scoring.

WHO-endorsed for TB screening and part of global TB elimination programs.

qER – Artificial Intelligence for Head CT scans

Detects life-threatening conditions in brain scans: bleeds, fractures, infarcts, Edema, etc.

Used in emergency rooms to prioritize high-risk cases immediately.

Clinically validated on several continents.

qTrack – For Follow-ups & Monitoring

Tracks lung nodules or chronic conditions over time.

Ensures consistent comparison and monitoring of progression—even without an identical radiologist.

Reach & Impact

90+ countries and growing

15+ million scans processed

Worked with WHO, Stop TB, AstraZeneca, Medtronic, PATH, Gates Foundation

66% cost savings in diagnostics

Used in over 30 clinical studies establishing accuracy and effectiveness

Their AI doesn't just match expert performance—it often accelerates diagnosis, reduces human error, and expands access to care in underserved populations.

Real-World Deployments

Mobile TB screening vans for Southeast Asia and Africa

Public emergency rooms and hospitals using qER for patients with trauma

Refugee camps using qXR to detect pneumonia and TB at an early stage

Airports and ports using qXR during the COVID-19 pandemic

Compatible with PACS, RIS, and cloud platforms

From villages in rural areas to metropolises across the globe, Qure.ai has not only made medical AI a concept—but a daily clinical reality.

What’s Next?

IPO expected by 2026, following massive global expansion

New products for cardiology, oncology, and population screening underway

Secured FDA clearances, CE marking, and launched in the U.S.

Deepening partnerships with top pharma, governments, and NGOs

Qure isn’t just catching diseases—it’s building a global health infrastructure layer powered by AI.

Want to keep learning about how AI is transforming healthcare and other vital industries? Subscribe or join the GAiF community today and stay inspired.